Flow Cytometry Markets: Forecasts by Technology, Product and Application with Executive and Consultant Guides Including Custom Forecasting 2022 to 2026
“Immuno-oncology frontier and liquid biopsy combine to create enormous market demand.…”
Publication date: April 7, 2022
Page count: 370
Flow Cytometry is a mainstay of analytical methods to study cells, but growth is now accelerating as new immuno-oncology and liquid biopsy markets create unprecedented investment in the race to cure cancer.
On top of this, new genome based knowledge is fostering a new generation of scientific exploration of single cells. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.
The report forecasts the market size out to 2026 by country, and by:
All report data is available in Excel format on request with the corporate license. Assistance and additional breakout data is also available free of charge with the corporate license.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options, however your order is available as a credit if you wish to upgrade. We wrote this report and are ready by phone or email to help you use it.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School